Genetic Data Is Communist China's Next Goal

Written By BlabberBuzz | Sunday, 24 October 2021 19:00

According to Michael Orlando, China and other strategic rivals use "both legal and illegal means to acquire American 'know-how'" which serves as acting director for National Counterintelligence and Security Center (NCSC), a branch of the Office of the Director of National Intelligence.

A new summary from the NCSC prompted the United States to do more to secure "critical technologies," including quantum computation, semiconductors, and emerging technology in the emerging bio-economy sector.

“For example, biotechnology can be misused to create virulent pathogens that can target. Our food supply or even the human population. Genomic technology used to design disease therapies tailored to an individual also can be used to identify genetic vulnerabilities in a population,” the summary said.

 WATCH: IRAN CLOSING IN ON NUCLEAR WARHEADSbell_image

 WATCH: IRAN CLOSING IN ON NUCLEAR WARHEADSbell_image

China aiming at American firms for corporate espionage and intellectual property theft is not a new thing. The CCP thinks that controlling developing and high-tech sectors like artificial intelligence will give it an economic advantage, or at the very least achieve "strategic parity" with the United States.

 MILITARY IN MICHIGAN FIGHTING VIRUS SURGEbell_image

 MILITARY IN MICHIGAN FIGHTING VIRUS SURGEbell_image

According to Edward You, the national counterintelligence officer for "emerging and disruptive technologies," the Chinese government is "collecting medical, health and genetic data around the world." In light of a coronavirus pandemic, the value of health data has grown increasingly relevant: "the country that builds the best database of information will have an 'edge' on developing cures for future pandemics, and China already has an advantage," You added.

 CHUCK SCHUMER MOURNS THE DEATH OF FATHERbell_image

 CHUCK SCHUMER MOURNS THE DEATH OF FATHERbell_image

China's track record of actions in Xinjiang included genetic experiments to "track" the Uyghur minority, according to a 2019 New York Times report. Attempts to receive genetic information have been ongoing for at least a decade. Chinese biotech company BGI, in partnership with the People's Liberation Army, produced a neonatal genetic test that has been used to collect genetic information on "millions." The NCSC notes that BGI received an unknown American genomics firm in 2013. It also stressed that WuXi, which owns a Pfizer manufacturing plant in China, made a substantial capital investment in 23andMe, a consumer genetics company, in 2015.p>

 HOLIDAY GIFTS STRUCK BY BIDENFLATIONbell_image

 HOLIDAY GIFTS STRUCK BY BIDENFLATIONbell_image

In short, "they are developing the world's largest bio database. Once they have access to your genetic data, it's not something you can change like a pin code." suggested Mr. You.

23AndMe fought back, expressing concerns that Chinese data theft is "misplaced." Jacquie Cooke Haggarty, the company's deputy general counsel, put out a statement that reads: "Wuxi has a less than 1% investment in 23andMe and has never received any customer data. No data has ever been shared with a Chinese-owned company and no investor has access to the data. All of our testing is performed and has always been performed in the U.S.-based laboratories."

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's

Start your own discussion or comment on someone else's